Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
29.10
-0.68 (-2.28%)
At close: Mar 28, 2025, 4:00 PM
29.50
+0.40 (1.37%)
After-hours: Mar 28, 2025, 7:45 PM EDT
Janux Therapeutics Employees
Janux Therapeutics had 81 employees as of December 31, 2024. The number of employees increased by 17 or 26.56% compared to the previous year.
Employees
81
Change (1Y)
17
Growth (1Y)
26.56%
Revenue / Employee
$130,716
Profits / Employee
-$851,778
Market Cap
1.72B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 81 | 17 | 26.56% |
| Dec 31, 2023 | 64 | 4 | 6.67% |
| Dec 31, 2022 | 60 | 27 | 81.82% |
| Dec 31, 2021 | 33 | 21 | 175.00% |
| Dec 31, 2020 | 12 | - | - |
JANX News
- 4 weeks ago - Janux Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights - Business Wire
- 2 months ago - Janux Therapeutics Promotes Zachariah McIver, D.O., Ph.D. to Chief Medical Officer - Business Wire
- 2 months ago - Janux Therapeutics: mCRPC TAM And Promising JANX007's Phase 1 Data - Seeking Alpha
- 3 months ago - Best-Performing Stocks Of 2024 - Seeking Alpha
- 4 months ago - Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters' Option to Purchase Additional Shares for Total Gross Proceeds of $402.5 Million - Business Wire
- 4 months ago - Janux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants - Business Wire
- 4 months ago - Janux Therapeutics Announces Proposed Public Offering - Business Wire
- 4 months ago - Janux Therapeutics' Prostate Cancer Trial Data Exceeds Investor Expectations: Analyst - Benzinga